Lv11
30 积分 2021-09-26 加入
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
3小时前
待确认
Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels
4个月前
已完结
Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity
4个月前
已完结
Resistance of Lenvatinib in Hepatocellular Carcinoma
4个月前
已完结
AXL Inhibitors: Status of Clinical Development
5个月前
已完结
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer
6个月前
已完结
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer
6个月前
已完结
Novel targets for immune-checkpoint inhibition in cancer
7个月前
已完结
Corn oil and Soybean oil effect as vehicles on behavioral and oxidative stress profiles in developmentally exposed offspring mice
7个月前
已完结
Ningetinib plus gefitinib in EGFR-mutant non-small-cell lung cancer with MET and AXL dysregulations: A phase 1b clinical trial and biomarker analysis
7个月前
已完结
皖公网安备34019202002308
